Table 3.

Primary and Secondary Post-CABG Outcomes

Outcome Variable	n3-PUFA (n=120)	Placebo (n=123)	P*
AF/flutter requiring therapy	36 (30%)	40 (33%)	0.67
Post-CABG length of stay, d, median (25th–75th percentile)	6 (5–8)	5 (4–7)	0.27†
Congestive heart failure	3 (2%)	2 (2%)	0.68
Sustained ventricular arrhythmias	1 (1%)	2 (2%)	1.0
Myocardial infarction	1 (1%)	1 (1%)	1.0
Bleeding requiring reoperation or transfusion	22 (18%)	15 (12%)	0.18‡
Infection	14 (12%)	13 (11%)	0.79‡
Renal failure	4 (3%)	4 (3%)	1.0
Respiratory failure	2 (2%)	3 (2%)	1.0
Stroke or transient ischemic attack	3 (2%)	3 (2%)	1.0
Rehospitalization for AF	1 (1%)	2 (2%)	1.0
Readmission to intensive care unit	7 (6%)	9 (7%)	0.64‡
Death within 30 d	0 (0%)	0 (0%)	1.0

Values are given as n (%) of patients unless otherwise noted.

^*Fisher exact test, except where indicated by † or ‡.

^†Wilcoxon rank-sum test.

^‡Pearson χ² test.